AVALA RES risk profile

36 Normal where most of the sector sits

Measured 1 September 2026 from CVJ's filed statements. Recomputed nightly.

36 (Normal), driven by Market expectation at 100, over 4 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation100AcuteStableDrawdown from the 52-week high — 96.2%
Operating pressure1ContainedStableInput-cost exposure — 0.02
Cash conversionReads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company.
Leverage and coverage100AcuteWorseningNet debt to EBITDA
Competitive position20NormalStableR&D-intensity gap against peers — -140.4 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for AVALA RES